Abstract:Background Intranasal fentanyl (INF) has gained popularity in pediatric emergency departments (EDs) as an effective alternative to intravenous morphine for treating acute moderate to severe pain. Intranasal fentanyl eliminates the need for invasive access, making it advantageous for patients with minor injuries. Our study aims to provide a comprehensive evaluation of the available evidence regarding the effectiveness and safety of INF administration in pediatric emergency wards, particularly compared with other treatment options described in the literature. Methods A thorough search strategy identified randomized controlled trials assessing INF in the pediatric emergency ward. Eligible studies were independently screened, and relevant data were extracted. The analysis used pooled risk ratio (RR) for dichotomous outcomes and the standardized mean difference (SMD) for continuous ones. Randomized controlled trials' quality was assessed using the Cochrane Risk of Bias Assessment Tool 2. Results In our study, 8 randomized controlled trials involving 806 patients, INF demonstrated superior effectiveness in reducing pain compared with other comparators at the 15- to 20-minute mark (SMD, −0.23; 95% confidence interval, −0.37 to −0.08; P = 0.002). However, no significant differences were found at the 30- and 60-minute time points (SMDs, −0.16; 95% CI, −0.50, 0.19; P = 0.37; and −0.16; 95% CI, −0.50 to 0.19; P = 0.78) except when excluding one study to resolve heterogeneity at the 30-minute mark (RR, −0.02; 95% CI, −0.24 to 0.20; P = 0.87). Intranasal fentanyl also exhibited a better adverse outcome profile, with a lower risk of total adverse events and nausea/vomiting (RR, 0.66; 95% CI, 0.48–0.91; P = 0.01; and RR, 0.43; 95% CI, 0.30–0.63; P > 0.001) compared with other analgesics. However, no significant differences were observed for dizziness and hallucination (RR, 0.43; 95% CI, 0.30–0.63; P = 0.68; and RR, 0.43; 95% CI, 0.30–0.63; P = 0.35). Conclusions Our study assessed the effectiveness of INF compared with other analgesics in pain reduction. Intranasal fentanyl demonstrated superior pain reduction at the 15- to 20-minute point but showed no significant differences at 30 and 60 minutes. Intranasal fentanyl also had a more favorable adverse event profile, with a lower risk of nausea and vomiting than other analgesics. However, no significant differences were observed in dizziness and hallucination between the groups.

What is the Evidence for Using Intranasal Medicine in the Prehospital Setting? A Systematic Review

The use of intranasal analgesia for acute pain control in the emergency department: A literature review

Evaluation of Intranasal Fentanyl and Midazolam Among Inpatient Pediatric Patients

Early intranasal medication administration in out-of-hospital cardiac arrest: Two randomized simulation trials

Efficacy and Safety of Intranasal Fentanyl in Pediatric Emergencies

Intranasal midazolam for procedural distress in children in the emergency department: a systematic review and meta-analysis

Inhaled analgesics for the treatment of prehospital acute pain—A systematic review

A qualitative study of emergency nurses perspectives on intranasal ketamine for procedural sedation in children

Pharmacokinetic Properties of an FDA‐approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose

Sedative and Behavioral Effects of Intranasal Midazolam in Comparison with Other Administrative Routes in Children Undergoing Dental Treatment - A Systematic Review

Efficacy and safety of intranasal dexmedetomidine versus oral chloral hydrate as sedatives for pediatric patients: a systematic review and meta-analysis

Nebulized Ketamine Used for Managing Ankle Fracture in the Prehospital Emergency Setting: A Case Report

Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest

Clinical Trials of Intranasal Delivery for Treating Neurological Disorders – a Critical Review

Respiratory support in the emergency department a systematic review and meta‐analysis

Nose-to-Heart Approach: Unveiling an Alternative Route of Acute Treatment

Adverse Effects After Prehospital Administration of Naloxone by Bystanders: A Preliminary Study

Comparing the Sedative Effects of Intranasal Dexmedetomidine, Midazolam, and Ketamine in Outpatient Pediatric Surgeries: A Randomized Clinical Trial

Intranasal administration of antiseizure medications in chronic and emergency treatment: Hopes and challenges

Intranasal dexmedetomidine vs. oral midazolam for premedication in children: a systematic review and meta-analysis

Comparison of intranasal midazolam-fentanyl with dexmedetomidine-fentanyl as pre-medication in the paediatric age group